खोज परिणाम - F. Buonfiglioli

  • प्रदर्शित 1 - 4 परिणाम 4
परिणाम को परिष्कृत करें
  1. 1
    Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

    Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals द्वारा Fabio Conti, F. Buonfiglioli, Alessandra Scuteri, Cristina Crespi, Luigi Bolondi, Paolo Caraceni, Francesco Giuseppe Foschi, Marco Lenzi, G. Mazzella, Gabriella Verucchi, Pietro Andreoné, S. Brillanti

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  2. 2
    Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals

    Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals द्वारा Federico Ravaioli, Fabio Conti, S. Brillanti, Pietro Andreoné, G. Mazzella, F. Buonfiglioli, Ilaria Serio, G. Verrucchi, Maria Letizia Bacchi Reggiani, Agostino Colli, Giovanni Marasco, Antonio Colecchia, Davide Festi

    प्रकाशित 2018
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  3. 3
    Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis

    Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis द्वारा Andrea Lisotti, Francesco Azzaroli, F. Buonfiglioli, Marco Montagnani, Paolo Cecinato, Laura Turco, Claudio Calvanese, Patrizia Simoni, Massimo Guardigli, Rosario Arena, Alessandro Cucchetti, Antonio Colecchia, Davide Festi, Rita Golfieri, G. Mazzella

    प्रकाशित 2013
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  4. 4
    Safety and efficacy of direct‐acting antivirals for the treatment of chronic hepatitis C in a real‐world population aged 65 years and older

    Safety and efficacy of direct‐acting antivirals for the treatment of chronic hepatitis C in a real‐world population aged 65 years and older द्वारा Fabio Conti, S. Brillanti, F. Buonfiglioli, Ranka Vukotic, Maria Cristina Morelli, Claudine Lalanne, Marco Massari, Francesco Giuseppe Foschi, Veronica Bernabucci, Ilaria Serio, G.M. Prati, Eva Negri, Lorenzo Badia, Paolo Caraceni, Paolo Muratori, Giovanni Vitale, A Porro, Marta Morotti, G. Mazzella, Pietro Andreoné

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:

खोज साधन: